Mereo BioPharma (MREO) Reports In-Line Q1 EPS

Mereo BioPharma (NASDAQ: MREO) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01).

For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• AT&T and Dallas Cowboys extend stadium naming rights deal
• German government to cut taxes on gasoline by 17 euro cents per litre - Reuters